ArticleAmerican journal of cancer research2023

Development of triazole-based PKC-inhibitors to overcome resistance to EGFR inhibitors in EGFR-mutant lung cancers.

Pei-Chih Lee et al.PubMed ↗Full text ↗

No numbers read from the abstract.